Global Industrial Microbiological QC Market Ascends at a Noteworthy CAGR of 5.69%

Introduction

Product safety is a global concern that is gaining public attention. Government regulators and product manufacturers focus on maintaining the highest possible product quality. The production environment is also monitored at regular intervals using microbiological tests. Industrial microbiological QC products and services are market offerings used to conduct microbiological quality control testing to enhance the quality of industrial products. Industrial microbiology is the subfield of applied microbiology concerned with using microorganisms in industrial processes, such as pharmaceutical drug development, testing for food pathogens, vaccine production, industrial fermentation, wastewater treatment, and industrial chemical treatment.

Market Dynamics

Multiple Industry Initiatives to Speed Up Technology Development Drives the Global Market

In recent years, the use of novel rapid detection technologies for screening microbes during quality control has increased, especially for evaluating raw materials, product stability, and product contamination, among other things. Due to the increasing importance of conducting industrial microbiological quality control testing at various stages of production, industry leaders are developing new methods for controlling microorganisms in an industrial process. Several key players, including new and established firms, are actively adopting key business strategies and product enhancements to contribute significantly to the global industrial microbiological QC market. In April 2021, for instance, Lonza Group AG expanded its PyroTec PRO Automated Robotic Solution for endotoxin testing. This will enable quality control (QC) microbiologists to select the endotoxin test methodology most suited to the testing needs.

Technological Advancement Led by Pharmaceutical and Biotechnology Industries Creates Tremendous Opportunities

The importance of quality control in the pharmaceutical and biotechnology industries has necessitated the development of technologically advanced methods for screening microbes at various stages of production. The market participants, including bioMérieux SA, F. Hoffmann-La Roche Ltd, Sartorius AG, and Lonza Group AG, are investing significantly in developing and introducing new products based on RT-PCR and NAT technologies. For instance, in July 2020, bioMerieux SA introduced its new BIOPIRE MYCOPLASMA, a nucleic acid amplification technique (NAT)-based method for detecting mycoplasma in pharmaceutical products for biotherapeutics. Consequently, the growing importance of developing technologically advanced products for conducting quality control tests throughout the pharmaceutical manufacturing process is anticipated to create lucrative opportunities in the global market for industrial microbiological QC.

Regional Analysis

Europe is the most significant shareholder global industrial microbiological QC market and is estimated to grow at a CAGR of 4.95% over the forecast period. Increasing research activities to develop new products for industrial microbiological quality control are primarily responsible for the region's economic expansion. In addition, the increasing number of laboratories offering testing services creates enormous market expansion opportunities in the region. The manufacturing companies in the region are proactive in adopting key business strategies, such as mergers and acquisitions and synergistic activities, to provide optimal solutions to end-users, thereby boosting the market's competitiveness. For instance, Primerdesign Ltd, a wholly-owned subsidiary of Novacyt S.A., partnered with the VGS Invest Holding Sarl Group in January 2020 to distribute certain molecular diagnostic products in France for the aquamarine and aquaculture markets. Following the terms of this partnership, molecular diagnostics products would be utilized for the early detection of diseases, including microbial infections, that affect animal health during food production. These business strategies will continue strengthening the overall industrial microbiological QC market scenario.

North America is anticipated to exhibit a CAGR of 5.18% over the forecast period. The United States dominated the global industrial microbiological QC market in terms of product revenue as a result of increasing research on the development of novel therapeutics, such as drugs for cell and gene therapy and immunotherapy, rising consumer awareness of food quality, and the emergence of more companies offering novel industrial microbiological QC products. During the assessment period, the demand for these products is anticipated to increase significantly since several major pharmaceutical and biotechnology companies focus on developing transformative medicines and diagnostics and the FDA's stringent regulations regarding microbial QC. Moreover, the increasing emphasis on standardizing guidelines for incorporating microbiological QC testing, particularly in the food and beverage, cosmetics, and dairy industries, is anticipated to boost demand for novel industrial microbiological QC products over the forecast period.

Key Highlights

• The global industrial microbiological QC market was valued at USD 13,847.35 million in 2022. It is estimated to reach USD 22,785.61 million by 2031, growing at a CAGR of 5.69% during the forecast period (2023–2031).
• Based on the offering, the global industrial microbiological QC market is divided into products and testing services. The testing services segment is the most significant contributor to the market and is expected to exhibit a CAGR of 5.60% over the forecast period.
• Based on technology, the global industrial microbiological QC market is divided into conventional culture-based methods and rapid microbiological methods. The rapid microbiological methods segment accounts for the largest market share and is anticipated to exhibit a CAGR of 7.24% over the forecast period.
• Based on application, the global industrial microbiological QC market is bifurcated into food and beverage testing, pharmaceutical testing, cosmetic and personal care testing, biotechnology testing, agriculture and fermentation testing, paper testing, water testing, environmental testing, and other industry testing. The skin tightening segment owns the highest market share and is predicted to exhibit a CAGR of 5.03% over the forecast period.
• Based on the end-user, the global industrial microbiological QC market is bifurcated into product testing laboratories, food and beverage companies, pharmaceutical and biotechnology companies, research and academic institutions, regulatory and environmental agencies, and others. The product testing laboratories segment dominates the global market and is predicted to exhibit a CAGR of 6.62% during the forecast period.
• Europe is the most significant shareholder global industrial microbiological QC market and is estimated to grow at a CAGR of 4.95% over the forecast period.

Competitive Players

Competitive Players

The key players in the global industrial microbiological QC market are 3M Company, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux S.A., Bruker Corporation, Charles River Laboratories International, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Lonza Group AG, Merck KGaA, and others.

Recent Developments

Market News

• In January 2023, AstraZeneca, a global biopharmaceutical company, contracted Australia-based LBT to conduct a comprehensive product development project for the company's new APAS (registered trademark) Pharma analysis module (artificial intelligence software) to be used on the APAS Independence instrument. The APAS Pharma analysis module will be designed to detect microbial growth on settle plates used for sterility monitoring during drug production.

• In July 2022, Merck announced that it would open its first Microbiology Application and Training (MAT) Laboratory in Jigani, Bengaluru. According to the science and technology company, this lab will provide facilities and technical expertise to support the development of India's life science community's microbial quality control capabilities.

Segmentation